Compound Detail
CHEMBL4781613
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4781613 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MOPUKGRNMJFASP-WEVVVXLNSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
477.6
MW (Da)
5.50
ALogP
8
HBA
2
HBD
98.3
PSA (Ų)
0.39
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.97
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| A549 | IC50 | = | 10820.0 | nM | 4.97 | Antiproliferation activity against human A549 cells assessed as reduction in cel... | 32912435 |
| HeLa | IC50 | = | 15330.0 | nM | 4.81 | Antiproliferation activity against human HeLa cells assessed as reduction in cel... | 32912435 |
| NCI-H1975 | IC50 | = | 17930.0 | nM | 4.75 | Antiproliferation activity against human NCI-H1975 cells harboring EGFR T790M/L8... | 32912435 |
| MCF7 | IC50 | = | 26770.0 | nM | 4.57 | Antiproliferation activity against human MCF7 cells assessed as reduction in cel... | 32912435 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32912435 | 10.1016/j.bmc.2020.115669 | A549 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | NCI-H1975 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | HeLa | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | MCF7 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | L02 | 1 |
| 32912435 | 10.1016/j.bmc.2020.115669 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine